CCRL2
C-C chemokine receptor-like 2
Also known as: ACKR5, CCRL2_HUMAN, CKRX, CRAM-A, CRAM-B, HCR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00421
- Gene
- CCRL2
- Ensembl
- ENSG00000121797
- Chromosome
- 3
- Canonical length
- 344 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a chemokine receptor like protein, which is predicted to be a seven transmembrane protein and most closely related to CCR1. Chemokines and their receptors mediated signal transduction are critical for the recruitment of effector immune cells to the site of inflammation. This gene is expressed at high levels in primary neutrophils and primary monocytes, and is further upregulated on neutrophil activation and during monocyte to macrophage differentiation. The function of this gene is unknown. This gene is mapped to the region where the chemokine receptor gene cluster is located. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
344 residues, UniProt reviewed canonical sequence.
>O00421|CCRL2
1 MANYTLAPED EYDVLIEGEL ESDEAEQCDK YDAQALSAQL VPSLCSAVFV IGVLDNLLVV
61 LILVKYKGLK RVENIYLLNL AVSNLCFLLT LPFWAHAGGD PMCKILIGLY FVGLYSETFF
121 NCLLTVQRYL VFLHKGNFFS ARRRVPCGII TSVLAWVTAI LATLPEFVVY KPQMEDQKYK
181 CAFSRTPFLP ADETFWKHFL TLKMNISVLV LPLFIFTFLY VQMRKTLRFR EQRYSLFKLV
241 FAIMVVFLLM WAPYNIAFFL STFKEHFSLS DCKSSYNLDK SVHITKLIAT THCCINPLLY
301 AFLDGTFSKY LCRCFHLRSN TPLQPRGQSA QGTSREEPDH STEVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCRL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- lung: 12 nTPM
- adipose tissue: 12 nTPM
- small intestine: 11 nTPM
- duodenum: 11 nTPM
- appendix: 11 nTPM
- colon: 11 nTPM
Single-cell type
- monocytes: 116 nCPM
- neutrophils: 66 nCPM
- hofbauer cells: 39 nCPM
- macrophages: 36 nCPM
- cdc: 22 nCPM
- goblet cells: 20 nCPM
Immune cell
- intermediate monocyte: 22 nTPM
- classical monocyte: 15 nTPM
- non-classical monocyte: 10 nTPM
- myeloid DC: 9.9 nTPM
- basophil: 8.8 nTPM
- NK-cell: 6.7 nTPM
Brain region
- cerebral cortex: 4 nTPM
- white matter: 3.4 nTPM
- pons: 3.3 nTPM
- thalamus: 2.8 nTPM
- medulla oblongata: 2.5 nTPM
- spinal cord: 2.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CCRL2.
Disease | ImmuneIEDB
Conditions an epitope on CCRL2 was assayed in.
- colonic benign neoplasm T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.78
- gnomAD pLI
- 0.37
- gnomAD missense Z
- -0.41
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium-mediated signaling
- cell chemotaxis
- chemotaxis
- G protein-coupled receptor signaling pathway
- immune response
- inflammatory response
- positive regulation of cytosolic calcium ion concentration
Molecular functions
- C-C chemokine binding
- C-C chemokine receptor activity
- CCR chemokine receptor binding
- chemokine receptor activity
- chemokine receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCRL2 as an antibody target. Whether an autoantibody or antibody against CCRL2 could matter depends on whether native CCRL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCRL2 is annotated at the cell surface, where native CCRL2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CCRL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...